Paper40596331
Engineering M13 bacteriophage to display HER2 mimotopes on pVIII for vaccine development.
Nazeri N and 6 others. Sci Rep, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Engineering M13 bacteriophage to display HER2 mimotopes on pVIII for vaccine development. Papers, record 40596331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40596331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Engineering M13 bacteriophage to display HER2 mimotopes on pVIII for vaccine development.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erb-b2 Receptor Tyrosine Kinases | Major topic |
| Cancer Vaccines | Major topic |
| Breast Neoplasms | Major topic |
| Bacteriophage M13 | Major topic |
| Vaccine Development | Major topic |
| Capsid Proteins | Major topic |
| Humans | |
| Trastuzumab | |
| Epitopes | |
| Female | |
| Molecular Docking Simulation |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34442452 | Breast Cancer Treatments: Updates and New Challenges. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442452 | PubMed |
| 2 | 24360619 | Treatment of HER2-positive breast cancer. | Breast | 2014 | https://conductscience.org/library/papers/24360619 | PubMed |
| 3 | 29209143 | Risk Factors and Preventions of Breast Cancer. | Int J Biol Sci | 2017 | https://conductscience.org/library/papers/29209143 | PubMed |
| 4 | 35372498 | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35372498 | PubMed |
| 5 | 36011047 | HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36011047 | PubMed |
| 6 | 19022660 | Her2-positive breast cancer: herceptin and beyond. | Eur J Cancer | 2008 | https://conductscience.org/library/papers/19022660 | PubMed |
| 7 | 34298754 | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298754 | PubMed |
| 8 | 31978707 | A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action. | Mol Immunol | 2020 | https://conductscience.org/library/papers/31978707 | PubMed |
| 9 | 20532501 | Anti-HER2 vaccines: new prospects for breast cancer therapy. | Cancer Immunol Immunother | 2010 | https://conductscience.org/library/papers/20532501 | PubMed |
| 10 | 34638281 | Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638281 | PubMed |
| 11 | 35026721 | Vaccination against Her-2/neu, with focus on peptide-based vaccines. | ESMO Open | 2022 | https://conductscience.org/library/papers/35026721 | PubMed |
| 12 | 33466691 | Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33466691 | PubMed |
| 13 | 30327365 | Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/30327365 | PubMed |
| 14 | 38400008 | An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy. | Viruses | 2024 | https://conductscience.org/library/papers/38400008 | PubMed |
| 15 | 37514992 | Epitopes and Mimotopes Identification Using Phage Display for Vaccine Development against Infectious Pathogens. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37514992 | PubMed |
| 16 | 37063776 | Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/37063776 | PubMed |
| 17 | 31989033 | Phage display as a tool for vaccine and immunotherapy development. | Bioeng Transl Med | 2020 | https://conductscience.org/library/papers/31989033 | PubMed |
| 18 | 33316575 | Phages in vaccine design and immunity; mechanisms and mysteries. | Curr Opin Biotechnol | 2021 | https://conductscience.org/library/papers/33316575 | PubMed |
| 19 | 37243023 | Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37243023 | PubMed |
| 20 | 15113650 | Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. | Vet Immunol Immunopathol | 2004 | https://conductscience.org/library/papers/15113650 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42826091 | Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42826091 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40596331
GET https://conductscience.org/api/papers/v1/40596331/references?page=2